Cell freezing medium for clinical use
AssigneeAbelzeta Inc.
InventorsFei Wang, Jiaping He, Dijun Zhao, Victor Liu, Dingzhu Yang
Life of this patent
Estimating the term…
Loading patent…
AssigneeAbelzeta Inc.
InventorsFei Wang, Jiaping He, Dijun Zhao, Victor Liu, Dingzhu Yang
Estimating the term…
Provided in the present invention is a cell freezing medium for clinical use. In particular, the cell freezing medium of the present invention comprises the following components: (1) human albumin; (2) cryoprotectant: the cryoprotectant comprises a combination of one or more of dimethyl sulfoxide, glycerol, and ethylene glycol; (3) a saline buffer; wherein the salt buffer is a solution containing Na+, K+, Mg+, Cl−, and CH3COO− ions; (4) a vitamin; and (5) an amino acid, wherein the human albumin concentration is 1%-20% (w/v). The cell, after long-term cryopreservation with the freezing medium of the present invention, has a high viability, and the cellular efficiency maintains a high uniformity. The grade of purity of the freezing medium of the present invention is the pharmaceutical grade or USP grade; and the freezing medium is safe and reliable for clinical use, and can be used or conventional adherent and suspension cells.
A cell cryopreservation solution for long-term storage of a mammalian stem cell, comprising:
Dependencies are inferred from the claim text.